Erythema multiforme major following docetaxel

Archives of Gynecology and Obstetrics

Volumn 271, Issue 3, 2005, Pages 267-269

  Moisidis, Christina ^a   Möbus, Volker ^a  

^a Eye Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; HYDROCORTISONE;

AGED; ARTICLE; BLISTER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; METASTASIS; OROPHARYNX; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; ULCER;

AGED; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; ERYTHEMA MULTIFORME; FEMALE; HUMANS; HYDROCORTISONE; TAXOIDS; TREATMENT OUTCOME;

EID: 17644382640     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0643-9     Document Type: Article

References (5)

1. Aventis Pharmaceuticals (2000) Taxotere prescribing information. Aventis Pharmaceuticals, Collegeville
2. Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J (1999) Nail changes secondary to docetaxel (taxotere). Dermatology 198:288-290
3. Eich D, Scharfletter-Kochanek K, Eich HT, Tantcheva-Poor I, Krieg T (2002) Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer. Am J Clin Oncol 25:599-602
4. Hassett G, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19:197-200
5. Various (2001) Cutaneous drug reaction case reports from the world literature. Am J Clin Dermatol 12:267-274